EFFECTS OF CYCLIC NUCLEOTIDES AND PROSTAGLANDINS ON NORMAL AND ABNORMAL HUMAN MYELOID PROGENITOR PROLIFERATIONTAETLE R; KOESSLER A.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 4; PP. 1223-1229; BIBL. 33 REF.Article

The role of transferrin receptors in hemopoietic cell growthTAETLE, R.Experimental hematology. 1990, Vol 18, Num 4, pp 360-365, issn 0301-472X, 6 p.Article

EFFECT OF SODIUM THIOSULFATE ON CIS-DICHLORODIAMMINEPLATINUM(II) TOXICITY AND ANTITUMOR ACTIVITY IN L1210 LEUKEMIAHOWELL SB; TAETLE R.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 611-616; BIBL. 17 REF.Article

PULMONARY HISTOPATHOLOGIC CHANGES ASSOCIATED WITH MELPHALAN THERAPYTAETLE R; DICKMAN PS; FELDMAN PS et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 3; PP. 1239-1245; BIBL. 30 REF.Article

IN VITRO GROWTH AND DRUG SENSITIVITY OF TUMOR COLONY-FORMING UNITS FROM HUMAN TUMOR XENOGRAFTSTAETLE R; KOESSLER AK; HOWEL SB et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 5; PP. 1856-1860; BIBL. 22 REF.Article

SIGNIFICANCE OF VARIATION IN SERUM THYMIDINE CONCENTRATION FOR THE MARROW TOXICITY OF METHOTREXATEHOWELL SB; MANSFIELD SJ; TAETLE R et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 4; PP. 221-226; BIBL. 32 REF.Article

THYMIDINE AND HYPOXANTHINE REQUIREMENTS OF NORMAL AND MALIGNANT HUMAN CELLS FOR PROTECTION AGAINST METHOTREXATE CYTOTOXICITYHOWELL SB; MANSFIELD SJ; TAETLE R et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 3; PP. 945-950; BIBL. 58 REF.Article

DRUG-INDUCED AGRANULOCYTOSIS: IN VITRO EVIDENCE FOR IMMUNE SUPPRESSION OF GRANULOPOIESIS AND A CROSS-REACTING LYMPHOCYTE ANTIBODYTAETLE R; LANE TA; MENDELSOHN J et al.1979; BLOOD; USA; DA. 1979; VOL. 54; NO 2; PP. 501-512; BIBL. 36 REF.Article

EFFECT OF INTERFERON ON COLONY FORMATION IN CULTURE BY BLAST CELL PROGENITORS IN ACUTE MYELOBLASTIC LEUKEMIATAETLE R; BUICK RN; MCCULLOCH EA et al.1980; BLOOD; ISSN 0006-4971; USA; DA. 1980; VOL. 56; NO 3; PP. 549-552; BIBL. 16 REF.Article

ABNORMAL MODULATION OF GRANULOCYTE/MACROPHAGE PROGENITOR PROLIFERATION BY PROSTAGLANDIN E IN CHRONIC MYELOPROLIFERATIVE DISORDERSTAETLE R; GUITTARD JP; MENDELSOHN JM et al.1980; EXP. HEMATOL.; ISSN 0301-472X; DNK; DA. 1980; VOL. 8; NO 10; PP. 1190-1201; BIBL. 28 REF.Article

Induction of colony-stimulating factor response in myeloid leukaemia cell linesRHYNER, K; TAETLE, R.British journal of haematology. 1986, Vol 64, Num 3, pp 601-612, issn 0007-1048Article

CHARACTERIZATION OF NORMAL PERIPHERAL BLOOD LYMPHOCYTE COLONY-FORMING CELLS: CELL CYCLE STATUS, SURFACE MARKERS, AND CELLULAR GROWTH REQUIREMENTSTAETLE R; TO D; CAVILES A et al.1983; BLOOD; ISSN 0006-4971; USA; DA. 1983; VOL. 61; NO 3; PP. 548-555; BIBL. 33 REF.Article

PLASMA CALCITONIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH SMALL CELL CARCINOMA OF THE LUNGWALLACH SR; ROYSTON I; TAETLE R et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 53; NO 3; PP. 602-606; BIBL. 16 REF.Article

In vitro sensitivity to steroid hormones and cytotoxic agents of normal and malignant lymphocyte colony-forming cells = Sensibilité, in vitro, aux hormones stéroïdes et aux agents cytotoxiques, des cellules normales et malignes formant des colonies de lymphocytesTAETLE, R; DONG TO; MENDELSOHN, J et al.Cancer research (Baltimore). 1983, Vol 43, Num 8, pp 3553-3558, issn 0008-5472Article

γ-interferon modulates human monocyte/macrophage transferrin receptor expressionTAETLE, R; HONEYSETT, J. M.Blood. 1988, Vol 71, Num 6, pp 1590-1595, issn 0006-4971Article

Transferrin modulation of colony stimulating factor elaboration by adherent blood and bone marrow cellsTAETLE, R; HONEYSETT, J. M.British journal of haematology. 1986, Vol 62, Num 1, pp 163-170, issn 0007-1048Article

COLONY-FORMING ASSAY FOR CIRCULATING CHRONIC LYMPHOCYTIC LEUKEMIA CELLSTAETLE R; RICHARDSON D; DONG TO et al.1982; LEUK. RES.; ISSN 0145-2126; USA; DA. 1982; VOL. 6; NO 3; PP. 335-344; BIBL. 37 REF.Article

CSF-responsive bone marrow cells in liquide culture; characterization and screening applicationsRHYNER, K; TAETLE, R.International journal of cell cloning. 1986, Vol 4, Num 1, pp 27-42, issn 0737-1454Article

Further studies on mechanisms of abnormal prostaglandin response by chronic myelogenous leukaemia granulocyte/macrophage progenitorsTAETLE, R; SHAO LI-EN.Leukemia research. 1984, Vol 8, Num 5, pp 833-842, issn 0145-2126Article

COMPARISON OF THE ACTIVITY OF DOXORUBICIN ANALOGUES USING COLONY-FORMING ASSAYS AND HUMAN XENOGRAFTSTAETLE R; HOWELL SB; GIULIANI FC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 8; PP. 1455-1461; BIBL. 22 REF.Article

Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisisRUSSELL, M; THOMPSON, F; SPIER, C et al.Leukemia. 1993, Vol 7, Num 10, pp 1654-1657, issn 0887-6924Article

Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cellsRHYNER, K; TAETLE, R; BERING, H et al.Journal of cellular physiology. 1985, Vol 125, Num 3, pp 608-612, issn 0021-9541Article

Preclinical evaluation of illudins as anticancer agents : basis for selective cytotoxicityKELNER, M. J; MCMORRIS, T. C; TAETLE, R et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 19, pp 1562-1565, issn 0027-8874Article

Regulation of transferrin receptor expression in myeloid leukemia cellsTAETLE, R; RALPH, S; SMEDSRUD, S et al.Blood. 1987, Vol 70, Num 3, pp 852-859, issn 0006-4971Article

In vitro and in vivo studies on the anticancer activity of dehydroilludin MKELNER, M. J; MCMORRIS, T. C; TAETLE, R et al.Anticancer research. 1995, Vol 15, Num 3, pp 873-878, issn 0250-7005Article